Walgreens Boots Non-GAAP EPS of $1.00 misses by $0.07, revenue of $35.42B beats by $1.3B
Walgreens Boots press release (NASDAQ:WBA): Q3 Non-GAAP EPS of $1.00  misses by $0.07.
Revenue of $35.42B (+8.7% Y/Y)  beats by $1.3B.
The fourth quarter is expected to be negatively impacted by a higher effective tax rate, shifting U.S. consumer spending with heightened macro pressures, and the impact of a weaker respiratory season for both U.S. Retail Pharmacy and U.S. Healthcare.

For the full fiscal year 2023, Walgreens Boots Alliance now expects adjusted EPS of $4.00 to $4.05 from $4.45 to $4.65 previously vs. consensus of $0.45, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.
Preliminary fiscal 2024 expectation for low- to mid-single digit adjusted operating income growth, expected to be driven by U.S. Healthcare and U.S. Retail Pharmacy; adjusted operating income growth expected to outpace adjusted EPS.